REGENXBIO Inc. RGNX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2015-09-17
Chart by TradingView
3/9
Piotroski F — financial health
-7.82
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $170.4M | $83.3M | $90.2M | $112.7M | $470.3M |
| Operating income | -$161.2M | -$233.3M | -$268.1M | -$262.9M | $160.0M |
| Net income | -$193.9M | -$227.1M | -$263.5M | -$280.3M | $127.8M |
| Operating cash flow | -$124.0M | -$173.1M | -$218.4M | -$207.5M | $218.9M |
| Free cash flow | -$126.4M | -$175.6M | -$228.4M | -$238.2M | $134.7M |
| Total assets | $453.0M | $466.0M | $574.0M | $833.3M | $1.1B |
| Total liabilities | $350.3M | $206.3M | $262.2M | $317.1M | $349.6M |
| Shareholders' equity | $102.7M | $259.7M | $311.7M | $516.2M | $764.3M |
| Ratios | |||||
| Operating margin | -94.6% | -280.0% | -297.1% | -233.2% | 34.0% |
| Net margin | -113.8% | -272.5% | -292.0% | -248.7% | 27.2% |
| FCF margin | -74.1% | -210.7% | -253.1% | -211.3% | 28.6% |
| Return on assets | -42.8% | -48.7% | -45.9% | -33.6% | 11.5% |
| Return on equity | -188.7% | -87.5% | -84.5% | -54.3% | 16.7% |
| Current ratio | 2.38 | 2.69 | 2.57 | 3.19 | 3.98 |
| Revenue growth | 104.5% | -7.7% | -19.9% | -76.0% | 204.3% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 305,286 | $2.6M |
| Point72 Asset Management, L.P. | 139,791 | $1.2M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -7.82 (distress)
- Working capital / assets 0.36
- Retained earnings / assets -2.486
- EBIT / assets -0.356
- Equity / liabilities 0.293
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001590877 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.